M MOBOCERTINIB (is an active metabolite) | MOBOCERTINIB | ATC L01EB10
ANTINEOPLASTIC KINASE INHIBITOR TREATMENT OF NSCLC WITH EGFR EXON 20 INSERTION MUTATIONS | - | PPB 98.6 PERCENT Cl 159 LITER / HOUR HT 18 HOUR | EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) (MUTATED) | Epidermal growth factor receptor UNIPROT P00533 more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |